|
Volumn 46, Issue 2, 2000, Pages 241-247
|
Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneumoniae: An in vitro comparison with pefloxacin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AF 3013;
DRUG METABOLITE;
PEFLOXACIN;
PRULIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BACTERICIDAL ACTIVITY;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EXPOSURE;
DRUG POTENTIATION;
IN VITRO STUDY;
INTRACELLULAR KILLING;
KLEBSIELLA PNEUMONIAE;
MACROPHAGE FUNCTION;
MALE;
MOUSE;
NONHUMAN;
PHAGOCYTOSIS;
TIME;
|
EID: 0033871704
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/46.2.241 Document Type: Article |
Times cited : (16)
|
References (19)
|